Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$693M |
| 2 |
Meta Platforms (Facebook)
META
|
+$446M |
| 3 |
Johnson & Johnson
JNJ
|
+$306M |
| 4 |
Evergy
EVRG
|
+$288M |
| 5 |
Walmart Inc
WMT
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Home Depot
HD
|
+$596M |
| 2 |
Booking.com
BKNG
|
+$519M |
| 3 |
Amazon
AMZN
|
+$518M |
| 4 |
Eli Lilly
LLY
|
+$268M |
| 5 |
UnitedHealth
UNH
|
+$246M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.51% |
| 2 | Technology | 14.39% |
| 3 | Financials | 11.76% |
| 4 | Consumer Discretionary | 9.46% |
| 5 | Real Estate | 8.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2176
Aspen Aerogels
ASPN
$339M
| $2.37M | ﹤0.01% |
483,800
+54,100
| +13% | +$257K |
|
2177
SiriusPoint
SPNT
$3.03B
| $2.37M | ﹤0.01% |
189,567
+133,367
| +237% | +$1.78M |
|
|
SCX
2178
DELISTED
The L.S. Starrett Company
SCX
| $2.37M | ﹤0.01% |
370,190
+12,690
| +4% | +$83.2K |
|
|
QIWI
2179
DELISTED
QIWI PLC
QIWI
| $2.37M | ﹤0.01% |
150,300
+18,847
| +14% | +$323K |
|
|
ARR
2180
Armour Residential REIT
ARR
$2.32B
| $2.36M | ﹤0.01% |
20,704
+14,285
| +223% | +$1.64M |
|
2181
BioLife Solutions
BLFS
$1.54B
| $2.36M | ﹤0.01% |
206,900
+179,100
| +644% | +$1.63M |
|
2182
Lifetime Brands
LCUT
$192M
| $2.36M | ﹤0.01% |
186,300
-4,900
| -3% | -$57.3K |
|
2183
Weyco Group
WEYS
$377M
| $2.35M | ﹤0.01% |
64,699
+14,999
| +30% | +$532K |
|
|
GMLP
2184
DELISTED
Golar LNG Partners LP
GMLP
| $2.35M | ﹤0.01% |
152,100
-128,100
| -46% | -$2.32M |
|
|
AGTC
2185
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $2.35M | ﹤0.01% |
634,500
+140,700
| +28% | +$651K |
|
|
GURE
2186
Gulf Resources
GURE
$4.88M
| $2.35M | ﹤0.01% |
33,982
+306
| +0.9% | +$21.7K |
|
2187
Karyopharm Therapeutics
KPTI
$155M
| $2.34M | ﹤0.01% |
+9,193
| New | +$2.27M |
|
2188
EyePoint Inc
EYPT
$999M
| $2.34M | ﹤0.01% |
112,430
-29,880
| -21% | -$586K |
|
|
MTLS
2189
Materialise
MTLS
$366M
| $2.33M | ﹤0.01% |
179,600
+57,300
| +47% | +$702K |
|
|
NTUS
2190
DELISTED
Natus Medical Inc
NTUS
| $2.32M | ﹤0.01% |
67,345
-98,600
| -59% | -$3.46M |
|
|
PTX
2191
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
| $2.32M | ﹤0.01% |
953,750
+12,500
| +1% | +$30.6K |
|
|
HIFR
2192
DELISTED
InfraREIT, Inc.
HIFR
| $2.32M | ﹤0.01% |
104,500
+21,300
| +26% | +$447K |
|
2193
Fresenius Medical Care
FMS
$13.4B
| $2.32M | ﹤0.01% |
46,000
-4,300
| -9% | -$218K |
|
2194
Harte-Hanks
HHS
$16.4M
| $2.31M | ﹤0.01% |
208,472
+23,232
| +13% | +$238K |
|
2195
Cumberland Pharmaceuticals
CPIX
$99.8M
| $2.31M | ﹤0.01% |
377,209
+23,709
| +7% | +$148K |
|
2196
Lexicon Pharmaceuticals
LXRX
$1.03B
| $2.31M | ﹤0.01% |
192,426
-36,660
| -16% | -$375K |
|
2197
BK Technologies
BKTI
$295M
| $2.3M | ﹤0.01% |
124,400
+500
| +0.4% | +$9.43K |
|
|
NVCN
2198
DELISTED
Neovasc Inc.
NVCN
| $2.3M | ﹤0.01% |
2,150
+1,921
| +839% | +$1.99M |
|
|
KREF
2199
KKR Real Estate Finance Trust
KREF
$466M
| $2.29M | ﹤0.01% |
+115,938
| New | +$2.33M |
|
|
CORV
2200
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
| $2.29M | ﹤0.01% |
605,423
+76,510
| +14% | +$200K |
|
Similar funds
Renaissance Technologies's Q2 2018 Portfolio in Review
As of Q2 2018, Renaissance Technologies held 3,750 positions worth $91.7B, up 0.34% from $91.4B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Renaissance Technologies withdrew a net $3.9B in Q2 2018, closing 524 positions and reducing 1,111 holdings. Its most notable exit was Booking.com, an estimated $519M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Technology and Financials.
Against the trend, Renaissance Technologies opened a new position in Apple worth $707M.
- Renaissance Technologies's largest Q2 2018 buy was Apple: 15,275,332 shares worth $707M.
- Renaissance Technologies added most to Johnson & Johnson in Q2 2018, an estimated $306M increase.
- Renaissance Technologies's biggest Q2 2018 reduction was Home Depot, cutting an estimated $596M.
- Renaissance Technologies fully exited Booking.com in Q2 2018, selling an estimated $519M.
- Renaissance Technologies's ten largest holdings make up 9.1% of its $91.7B portfolio in Q2 2018.
- Renaissance Technologies opened 412 new positions and closed 524 in Q2 2018.
- Renaissance Technologies's portfolio value rose 0.34% quarter-over-quarter to $91.7B.
Based on Renaissance Technologies's 13F filing for Q2 2018, filed 13 Aug 2018.